CAD 0.16
(-25.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -1.06 Million CAD | 15.26% |
2022 | -1.25 Million CAD | -10.89% |
2021 | -1.12 Million CAD | 62.96% |
2020 | -3.04 Million CAD | -793.52% |
2019 | -340.89 Thousand CAD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 Q4 | -1.06 Million CAD | 2.02% |
2023 Q1 | -1.19 Million CAD | 4.71% |
2023 Q2 | -1.11 Million CAD | 6.79% |
2023 Q3 | -1.08 Million CAD | 2.64% |
2022 Q1 | -1.05 Million CAD | 6.19% |
2022 Q4 | -1.25 Million CAD | -37.41% |
2022 Q3 | -910.57 Thousand CAD | 11.66% |
2022 Q2 | -1.03 Million CAD | 2.62% |
2022 FY | -1.25 Million CAD | -10.89% |
2021 Q2 | -1.8 Million CAD | 26.28% |
2021 FY | -1.12 Million CAD | 62.96% |
2021 Q4 | -1.12 Million CAD | 23.22% |
2021 Q3 | -1.46 Million CAD | 18.54% |
2021 Q1 | -2.44 Million CAD | 19.66% |
2020 Q4 | -3.04 Million CAD | 0.0% |
2020 FY | -3.04 Million CAD | -793.52% |
2019 FY | -340.89 Thousand CAD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | -125.08 Thousand CAD | -747.601% |
Asep Medical Holdings Inc | -44.72 Thousand CAD | -2270.748% |
BetterLife Pharma Inc. | 207.85 Thousand CAD | 610.09% |
BioVaxys Technology Corp. | -977.00 CAD | -108418.117% |
ChitogenX Inc. | 3.84 Million CAD | 127.61% |
Rapid Dose Therapeutics Corp. | 2.29 Million CAD | 146.245% |
Defence Therapeutics Inc. | 1.68 Million CAD | 162.739% |
Entheon Biomedical Corp. | -344.63 Thousand CAD | -207.638% |
Gemina Laboratories Ltd. | 284.33 Thousand CAD | 472.876% |
Glow Lifetech Corp. | 116.15 Thousand CAD | 1012.804% |
Lexston Life Sciences Corp. | -390.4 Thousand CAD | -171.57% |
Pharmala Biotech Holdings Inc. | 58.49 Thousand CAD | 1912.5% |
MYND Life Sciences Inc. | 2.99 Million CAD | 135.344% |
Nova Mentis Life Science Corp. | -8088.00 CAD | -13008.581% |
PharmaTher Holdings Ltd. | -2.13 Million CAD | 50.3% |
PreveCeutical Medical Inc. | 3.83 Million CAD | 127.662% |
Telescope Innovations Corp. | -719.49 Thousand CAD | -47.357% |